智能中医：中西医结合诊治心血管疾病的新方向

WANG Zi-yan; GUO Zhi-hua

doi:10.1007/s11655-023-3639-7

Your Location：

Home >

Browse articles >

智能中医：中西医结合诊治心血管疾病的新方向

Thinking and Methods | Updated：2023-06-27

- 智能中医：中西医结合诊治心血管疾病的新方向
- Intelligent Chinese Medicine: A New Direction Approach for Integrative Medicine in Diagnosis and Treatment of Cardiovascular Diseases^*
- 中国结合医学杂志（英文版） 2023年29卷第7期页码：634-643
- Affiliations：
  
  1.The First Clinical College of Chinese Medicine, Hunan University of Chinese Medicine, Changsha (410208), China
  2.School of Traditional Chinese Medicine, Hunan University of Chinese Medicine, Changsha (410208), China
  3.Hunan Key Laboratory of Colleges and Universities of Intelligent Traditional Chinese Medicine Diagnosis and Preventive Treatment of Chronic Diseases of Hunan Universities of Chinese Medicine, Changsha (410208), China
- Author bio：
  
  Prof. GUO Zhi-hua, E-mail: guozhihua112@163.com
- Funds：
  
  the National Natural Science Foundation of China(82174343;81673955);Key R&D Plan of Hunan Province(2022SK2012)
- DOI：10.1007/s11655-023-3639-7
  中图分类号：
- 纸质出版日期：2023-07，
  
  网络出版日期：2023-05-24，
  
  录用日期：2023-04-07
Scan for full text
智能中医：中西医结合诊治心血管疾病的新方向[J]. 中国结合医学杂志（英文版）, 2023,29(7):634-643.

WANG Zi-yan, GUO Zhi-hua. Intelligent Chinese Medicine: A New Direction Approach for Integrative Medicine in Diagnosis and Treatment of Cardiovascular Diseases^*[J]. Chinese Journal of Integrative Medicine, 2023,29(7):634-643.
智能中医：中西医结合诊治心血管疾病的新方向[J]. 中国结合医学杂志（英文版）, 2023,29(7):634-643. DOI： 10.1007/s11655-023-3639-7.

WANG Zi-yan, GUO Zhi-hua. Intelligent Chinese Medicine: A New Direction Approach for Integrative Medicine in Diagnosis and Treatment of Cardiovascular Diseases^*[J]. Chinese Journal of Integrative Medicine, 2023,29(7):634-643. DOI： 10.1007/s11655-023-3639-7.

摘要

在世界范围内心血管疾病 (CVDs) 死亡率居高不下

且老年人患心血管疾病的风险较高. 鉴于目前心血管疾病的治疗成本很高

因此有必要预防心血管疾病和 (或) 开发替代治疗方案. 西医和中医均被用于治疗心血管疾病. 然而

一些因素如诊断不准确、处方不规范、依从性差

降低了中医药治疗心血管疾病的疗效. 人工智能 (AI) 越来越多地应用于临床诊断和治疗

特别是通过临床决策支持系统、健康管理、新药研发和疗效评价等方面评价中医药的作用. 在本研究中

我们探讨了人工智能在中医药诊断和治疗心血管疾病中的作用

以及人工智能在中医药治疗心血管疾病疗效评价中的应用.

Abstract

High mortality rates from cardiovascular diseases (CVDs) persist worldwide. Older people are at a higher risk of developing these diseases. Given the current high treatment cost for CVDs

there is a need to prevent CVDs and or develop treatment alternatives. Western and Chinese medicines have been used to treat CVDs. However

several factors

such as inaccurate diagnoses

non-standard prescriptions

and poor adherence behavior

lower the benefits of the treatments by Chinese medicine (CM). Artificial intelligence (AI) is increasingly used in clinical diagnosis and treatment

especially in assessing efficacy of CM in clinical decision support systems

health management

new drug research and development

and drug efficacy evaluation. In this study

we explored the role of AI in CM in the diagnosis and treatment of CVDs

and discussed application of AI in assessing the effect of CM on CVDs.

关键词

中医西医人工智能心血管疾病缺血性心脏病心力衰竭

Keywords

Chinese medicineWestern medicineartificial intelligencecardiovascular diseasesischemic heart diseaseheart failure

references

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Astragaloside Ⅳ for Heart Failure: Preclinical Evidence and Possible Mechanisms, A Systematic Review and Meta-Analysis^*

Shexiang Tongxin Dropping Pill Allieviates Heart Failure via Extracellula Matrix-Receptor Interaction Pathways Based on RNA-Seq Transcriptomics and Experimental Studies^*

Bloodletting Acupuncture at Jing-Well Points Alleviates Myocardial Injury in Acute Altitude Hypoxic Rats by Activating HIF-1α/BNIP3 Signaling-Mediated Mitochondrial Autophagy and Decreasing Oxidative Stress

Therapeutic Efficacy of Shexiang Baoxin Pill Combined with Exercise in Patients with Heart Failure with Preserved Ejection Fraction: A Single-Center, Double-Blind, Randomized Controlled Trial